Imai R, Ashizawa T, Urakawa C, Morimoto M, Nakamura N
Gan. 1980 Aug;71(4):560-2.
The antitumor activity of 7-N-phenyl derivatives of mitomycin C was tested in an ip-ip system of mouse leukemia P388 by single administration. The compounds tested were 7-N-phenyl-, 7-N-(p-aminophenyl)-, 7-N-(p-hydroxyphenyl)- and 7-N-(p-chlorophenyl)-mitomycin C. The maximum increases in life span (ILSmax) obtained were 124, 169, > 386 and 112%, respectively, that with mitomycin C being 104%. 7-N-(p-Hydroxyphenyl)-mitomycin C showed a higher ILS% than its ortho and meta isomers. Thus, 7-N-(p-hydroxyphenyl)-mitomycin C was the most effective of these compounds.
通过单次给药,在小鼠白血病P388的腹腔注射-腹腔注射系统中测试了丝裂霉素C的7-N-苯基衍生物的抗肿瘤活性。所测试的化合物为7-N-苯基-、7-N-(对氨基苯基)-、7-N-(对羟基苯基)-和7-N-(对氯苯基)-丝裂霉素C。获得的最大寿命延长率(ILSmax)分别为124%、169%、>386%和112%,丝裂霉素C的为104%。7-N-(对羟基苯基)-丝裂霉素C的ILS%高于其邻位和间位异构体。因此,7-N-(对羟基苯基)-丝裂霉素C是这些化合物中最有效的。